Suppr超能文献

甲氟喹在人体中的单剂量动力学。原形药物及其一种代谢物的血浆水平。

Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites.

作者信息

Schwartz D E, Eckert G, Hartmann D, Weber B, Richard-Lenoble D, Ekue J M, Gentilini M

出版信息

Chemotherapy. 1982;28(1):70-84. doi: 10.1159/000238062.

Abstract

Oral single dose kinetics of mefloquine was investigated in 16 male volunteers, 3 Caucasians and 13 African natives. Unchanged mefloquine (= M) and one of its metabolites (= MM) were measured in the plasma. The apparent half-life of absorption of M ranged from 0.36 to 2.0 h, its terminal half-life of elimination from 15 to 33 days. Assuming complete systemic availability, an apparent volume of distribution of 14-29 liters x kg-1 and a total clearance of 18-39 ml x min-1 were derived. MM given orally to mice or rats showed at equal dose the same tolerance as mefloquine. Following oral administration of M to man, plasma levels of MM surpassed those of M, resulting in a 2.4-5.1 larger AUC. However, because of its much smaller apparent volume of distribution, MM may be anticipated to represent only a small percentage of the dose and therefore to contribute only to a minor extent towards the unwanted side effects of the drug.

摘要

在16名男性志愿者(3名高加索人及13名非洲本地人)中研究了甲氟喹的口服单剂量动力学。测定了血浆中未代谢的甲氟喹(=M)及其一种代谢产物(=MM)。M的表观吸收半衰期为0.36至2.0小时,其终末消除半衰期为15至33天。假设系统完全可用,得出表观分布容积为14 - 29升×千克⁻¹,总清除率为18 - 39毫升×分钟⁻¹。给小鼠或大鼠口服MM,在相同剂量下显示出与甲氟喹相同的耐受性。给人口服M后,血浆中MM的水平超过了M,导致AUC大2.4 - 5.1倍。然而,由于其表观分布容积小得多,可以预期MM仅占剂量的一小部分,因此对药物不良副作用的贡献也仅为次要程度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验